The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 4 rounds in the feed, most often at Series A and in Biotech.
Venture capitalangeliniventures.comRounds from 2025-10-16 to 2026-10-08
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
MMI (Medical Microinstruments) A surgical-robotics company that makes the Symani system for microsurgery and super-microsurgery | Series D Verified against 4 of 24 sources | $125M | 2026-10-08 | [ PART ] |
Rouge Therapeutics A provider of first-in-class disease-modifying therapies designed to restore vascular integrity | Series A |
| $58M |
| 2026-10-06 |
| [ LEAD ] |
Aptadir Therapeutics A preclinical biotech company developing a new class of RNA therapeutics | Seed Verified against 1 of 40 sources | $44.7M | 2026-09-29 | [ PART ] |
ADCytherix Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer. | Series A Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $122.3M | 2025-10-16 | [ LEAD ] |